HistoSonics

[PRIVATE]

Service & Cobot Robotics · HQ: Plymouth, MN · Est. 2009 · 1 model registered · 14 deployments

New deployment

As of Sep 2026, DEPLOY verifies HistoSonics: 1 model, 14 deployments across 11 regions, $102.0M raised. 4 sources back the record.

Ownership

PRIVATE

Capital / Funding

$102M

Headquarters

Plymouth, MN

IP / Patents

Undisclosed

Platform Models

1

Audited Incidents

0

Overview

Plymouth, Minnesota-based medical device company developing the Edison Histotripsy System — a robotically assisted platform using focused ultrasound to non-invasively destroy liver tumors. FDA De Novo clearance October 2023. Raised $102M Series D led by Alpha Wave Ventures, valued at $3.75B. Expanding to kidney, pancreas, prostate applications.

Audited Posture AssessmentPeer Percentile: 100.0%

Clean safety record across 14 verified deployments. Strong deployment footprint with 14 operational sites across 14 countries. Limited public visibility and press coverage relative to peers.

  • SURGICAL

Key Facts

Funding$102M Series D + $2B+ acquisition
CEOMike Blue
Form factorSurgical (histotripsy / focused ultrasound)
FDA statusDe Novo authorized 2023 (liver); kidney pending
CE MarkJuly 2026
Founded2009
StageCommercial (FDA-cleared)
ProductEdison Histotripsy System (FDA De Novo cleared Oct 2023)
Total funding$102M+ Series D (Alpha Wave Ventures led)
Valuation$3.75B (2026)
FDA pathwayDe Novo clearance for liver tumor destruction
InvestorsAlpha Wave Ventures, Amzak Health, HealthQuest Capital, J&J Innovation

Safety & Regulatory Posture

0 entries
Audited Incident & Recall Footprint

No incidents on record for HistoSonics.

Leadership & Founders

1 entry

Current Program Leadership & Executives

Steve Augustinereported, not verified

CEO

Partnerships & Commercial Deployments

2 entries
Total Tracked0
Operating0
Announced0
Concluded0

Operator Customers & Fleet Integrators

HistoSonics - 14 deploymentsHistoSonics

Platform Models

1 entry

Deployments

14 entries

Sectors & Applications

1 entry

FAQ

14 entries
What is HistoSonics?

Plymouth, Minnesota-based medical device company developing the Edison Histotripsy System — a robotically assisted platform using focused ultrasound to non-invasively destroy liver tumors. FDA De Novo clearance October 2023. Raised $102M Series D led by Alpha Wave Ventures, valued at $3.75B. Expanding to kidney, pancreas, prostate applications.

What does HistoSonics make?

HistoSonics has 1 robot model on the DEPLOY registry: Edison Histotripsy System (HistoSonics builds physical robots).

Is HistoSonics publicly traded?

No. HistoSonics is privately held and not publicly traded, per the DEPLOY registry.

Who competes with HistoSonics?

On the DEPLOY registry, peer companies to HistoSonics building in the same form factors include Brainlab, EndoQuest Robotics, Intuitive Surgical, LEM Surgical.

Who is the CEO of HistoSonics?

Steve Augustine is the ceo of HistoSonics, per the DEPLOY registry.

How can I invest in HistoSonics?

HistoSonics is a private company; its shares are not available on public markets, so retail investors cannot buy the stock today. It has raised $102M in disclosed funding.

Where is HistoSonics headquartered?

HistoSonics is headquartered in Plymouth, MN, USA.

How much funding has HistoSonics raised?

HistoSonics has raised approximately $102M in disclosed funding on record in the DEPLOY registry.

Who owns HistoSonics?

HistoSonics is privately held and venture-backed ($102M raised); ownership sits with its founders and private investors.

Where does HistoSonics operate robots?

HistoSonics operates 14 verified deployments, including at Cambridge University Hospital, Banner Gateway Medical Center, Miami, Florida, USA.

How many robots has HistoSonics deployed?

DEPLOY has 14 verified HistoSonics deployments on record at sites including Cambridge University Hospital, Banner Gateway Medical Center, Miami, Florida, USA. That is a count of distinct field deployments each backed by sourced evidence, not a manufacturer's claimed unit total; it updates as new sites are verified.

Is HistoSonics a top robotics company?

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, HistoSonics ranks in roughly the top under 1% of companies tracked by the registry.

When was HistoSonics founded?

HistoSonics was founded in 2009.

Is HistoSonics safe?

HistoSonics has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.